The peptides GMA4CG_WT and GMA4CG_V1–V6 were chemically synthesized with an initial purity of about 80%–85% from multiple commercial vendors and further purified using a C‐18 reverse phase HPLC as previously described (Velivelli et al., 2020 (link)). The HPLC fractions containing the peptide were lyophilized and resuspended in nuclease‐free water. Peptide concentrations were determined using the BCA assay. For peptides containing Trp, the peptide concentration was also determined using NanoDrop 2000c spectrophotometry (Thermo Fisher Scientific) to confirm concentrations determined by the BCA assay.